Insight and analysis on important legal issues affecting life sciences, mHealth, digital health and healthcare IT.
Last September, we noted that payers and providers were expected to become increasingly active digital health strategic investors given their challenges to improve margins and outcomes.
While there were only three investments by payer/providers in the second half of 2016, we saw a notable uptick in investment activity in the first quarter of 2017, when…
If your work involves life sciences dealmaking, you know it’s the time of year to start firming up your plans for the week of the J.P. Morgan Healthcare Conference. In the last 10 years, the second week of January in San Francisco has evolved from a J.P. Morgan private meeting for healthcare investors to a week…
Investors are increasingly interested in companies with technologies that will be subject to U.S. Food and Drug Administration (FDA) regulation.
Until recently, some investors shied away from companies targeting the regulated space out of concern that the regulatory landscape created too much risk. However, thanks in part to new guidance from the FDA regarding the…
A few months ago, following our fifth annual Digital Health Summit, the attendees made some predictions about product development and investment in the rapidly growing sector. Now that we are more than halfway through the year, we thought it would be interesting to see how those predictions fared against the investment results from the…
Fenwick’s fifth annual Digital Health Investor Summit brought together investors who are active in the digital health space to discuss the evolving digital health sector and their investment outlook for the year ahead.
Here are my three key takeaways from this year’s Summit:
Playing in the Regulated Space
The consensus is it’s time to stop…
Among its list of defining quotes of 2015, Rock Health included one from a physician who was frustrated with the fact that, as she put it, “In my hospital there are 19 software systems across departments – few of which communicate with each other.” The lack of standardization for health care software goes a long…
Our analysis of digital health investment in the third quarter of 2015 revealed that just under $3 billion was invested in the sector and more than half of that went to infrastructure providers.
Infrastructure
A total of $1.48 billion was invested in health infrastructure technology in Q3. The two largest infrastructure investments of the quarter…
At our Digital Health Summit earlier this year, Malay Gandhi, Managing Director at Rock Health, noted that once digital health venture investing accounts for 10% of all venture investment, we should start breaking out investment by industry subsectors.
That made us think it might be interesting to look at our monthly download of digital health…
Our fourth annual Digital Health Summit brought together a select group of investors active in the digital health, life sciences, medical device, and healthcare industries for a one-day meeting to discuss the future of digital health. Here are my top takeaways from this year’s summit:
…
Two blockbuster deals drove digital health financings to record levels in April. The month saw a total of nearly $790 million in deal flow, with the ten largest financing transactions of the month matching the first quarter total.
…
Continue Reading Jawbone and Oscar Lead Record Breaking Month for Digital Health Financings
Cookies on our website
We use cookies to improve the experience of our website. By continuing to use our website, you consent to the use of cookies. To understand more about how we use cookies, please see our Privacy Policy
